Cargando…

Response and resistance to CDK12 inhibition in aggressive B-cell lymphomas

Despite significant progress in the treatment of patients with diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL), the prognosis of patients with relapsed disease remains poor due to the emergence of drug resistance and subsequent disease progression. Identification of novel target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Jing, Wang, Michelle Y., Ren, Yuan, Lwin, Tint, Li, Tao, Yan, Joy C., Sotomayor, Eduardo M., Duckett, Derek R., Shah, Bijal D., Shain, Kenneth H., Zhao, Xiaohong, Tao, Jianguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052927/ https://www.ncbi.nlm.nih.gov/pubmed/34162179 http://dx.doi.org/10.3324/haematol.2021.278743

Ejemplares similares

MCL-1 dependency as a novel vulnerability for aggressive B cell lymphomas
por: Wang, Michelle Y., et al.
Publicado: (2021)

Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma
por: Zhao, Xiaohong, et al.
Publicado: (2021)

Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
por: Zhao, Xiaohong, et al.
Publicado: (2017)

Epigenetics, c-Myc and Aggressive B-cell Lymphomas
por: Zhang, Yizhuo, et al.
Publicado: (2012)

CDK12 and HER2 coamplification in two urothelial carcinomas with rapid and aggressive clinical progression
por: Yanai, Yoshinori, et al.
Publicado: (2020)

Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series
por: Iwasawa, Tomohiro, et al.
Publicado: (2022)

Nuances in the Management of Aggressive Lymphomas
por: Hamlin, Paul A., et al.
Publicado: (2017)

Cyclin K goes with Cdk12 and Cdk13
por: Kohoutek, Jiri, et al.
Publicado: (2012)

A case report of primary adrenal lymphoma: A rare but aggressive and invasive disease
por: Yang, Yunyun, et al.
Publicado: (2020)

Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
por: Zeng, Mei, et al.
Publicado: (2018)

Novel Therapies for Aggressive B-Cell Lymphoma
por: Foon, Kenneth A., et al.
Publicado: (2012)

CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo
por: Gregory, G P, et al.
Publicado: (2015)

Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center‐derived B‐cell lymphomas
por: Tanaka, Yuka, et al.
Publicado: (2020)

The emerging roles of CDK12 in tumorigenesis
por: Paculová, Hana, et al.
Publicado: (2017)

CDK13 cooperates with CDK12 to control global RNA polymerase II processivity
por: Fan, Zheng, et al.
Publicado: (2020)

Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
por: Cesari, Eleonora, et al.
Publicado: (2023)

Aggressive B-Cell Lymphomas
por: Naresh, Kikkeri N., et al.
Publicado: (2012)

Molecular Profiling of Aggressive Lymphomas
por: Rossi, Maura, et al.
Publicado: (2012)

Addressing the Challenges of Aggressive Lymphomas
por: Byar, Katherine L., et al.
Publicado: (2020)

Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13
por: Yang, Jianzhang, et al.
Publicado: (2022)

Diagnostic challenges in an aggressive case of peripheralizing marginal zone lymphoma
por: Shah, Sujal I., et al.
Publicado: (2020)

A case report of aggressive course of CD30+ primary cutaneous anaplastic large cell lymphoma
por: Lyu, Wen-Tian, et al.
Publicado: (2021)

CDK12 regulates co-transcriptional splicing and RNA turnover in human cells
por: Magnuson, Brian, et al.
Publicado: (2022)

MYC up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastoma
por: Pitolli, Consuelo, et al.
Publicado: (2023)

Orbital Burkitt's Lymphoma: An Aggressive Presentation
por: Giuliari, Gian Paolo, et al.
Publicado: (2012)

CDK2 regulates aminoglycoside-induced hair cell death through modulating c-Jun activity: Inhibiting CDK2 to preserve hearing
por: Tao, Litao, et al.
Publicado: (2022)

Tubular-specific CDK12 knockout causes a defect in urine concentration due to premature cleavage of the slc12a1 gene
por: Wang, Bin, et al.
Publicado: (2022)

B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapy
por: Zhang, Xiaohui, et al.
Publicado: (2017)

CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
por: Thieme, Elana, et al.
Publicado: (2023)

Targeting transcription in heart failure via CDK7/12/13 inhibition
por: Hsu, Austin, et al.
Publicado: (2022)

Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex
por: Ekumi, Kingsley M., et al.
Publicado: (2015)

JWA suppresses proliferation in trastuzumab-resistant breast cancer by downregulating CDK12
por: Liang, Yan, et al.
Publicado: (2021)

Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma: An Underrecognized Aggressive Lymphoma
por: Morgan, Elizabeth A., et al.
Publicado: (2012)

The structure and substrate specificity of human Cdk12/Cyclin K
por: Bösken, Christian A., et al.
Publicado: (2014)

Cdk12 is essential for embryonic development and the maintenance of genomic stability
por: Juan, H-C, et al.
Publicado: (2016)

CDK12 Activity-Dependent Phosphorylation Events in Human Cells
por: Bartkowiak, Bartlomiej, et al.
Publicado: (2019)

Analysis of CDK12 alterations in a pan‐cancer database
por: Pan, Elizabeth, et al.
Publicado: (2021)

AR-A014418 regulates intronic polyadenylation and transcription of PD-L1 through inhibiting CDK12 and CDK13 in tumor cells
por: Zhang, Ganggang, et al.
Publicado: (2023)

Autologous Stem Cell Transplantation for Aggressive Lymphomas
por: Visani, Giuseppe, et al.
Publicado: (2012)

Management of aggressive lymphoma in very elderly patients
por: Thieblemont, Catherine, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u5nloik7bso6tivud9r0b5fnm5